Time course of the effects of lisdexamfetamine dimesylate in two phase 3, randomized, double‐blind, placebo‐controlled trials in adults with binge‐eating disorder

OBJECTIVE: This study examined the time course of efficacy‐related endpoints for lisdexamfetamine dimesylate (LDX) versus placebo in adults with protocol‐defined moderate to severe binge‐eating disorder (BED). METHODS: In two 12‐week, double‐blind, placebo‐controlled studies, adults meeting DSM‐IV‐T...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Int J Eat Disord
Main Authors: McElroy, Susan L., Hudson, James I., Gasior, Maria, Herman, Barry K., Radewonuk, Jana, Wilfley, Denise, Busner, Joan
Formato: Artigo
Idioma:Inglês
Publicado em: John Wiley and Sons Inc. 2017
Assuntos:
Original Articles
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC5573905/
https://ncbi.nlm.nih.gov/pubmed/28481434
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/eat.22722
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados